logo-loader
viewConAgra Brands Inc

Conagra Brands, Allergan, Accenture, Nike and more - PRE-MARKET

Proactive takes a look at the stocks piquing interest before the bell in New York

1513861941_rsz_shutterstock_339902468.jpg
Conagra Brands gained over 3% in pre-market trade.

Conagra Brands Inc (NYSE:CAG) shares gained over 3% in pre-market to US$39.35 each.

It comes as the group inks a deal to acquire the Sandwich Bros of Wisconsin for an undisclosed amount.

 

In its second quarter, net sales grew 4.1% and organic net sales grew 2.3% in the three months with growth in each operating segment.

For the full fiscal 2018, Conagra now expects organic net sales and adjusted EPS to be near the high end of their respective guidance ranges.

Elsewhere, in pre market Allergan plc (NYSE:AGN) is in focus with shares up a tad - 0.05% -  as it reported that the FDA (Food & Drug Administration) had accepted a NDA (new drug application) for Seysara for the  treatment of moderate to severe acne.

Accenture Plc (NYSE:ACN) shares gained almost 2%  to US$154.75 as the  group reported a better-than-expected quarterly profit, as the outsourcing services provider gained from its push into digital and cloud services.

The tech group forecasts current-quarter revenue to come in between US$9.15bn and US$9.40bn, the low end of which was in line with analysts'  forecasts.

Nike Inc (NYSE:NKE) shares added 0.55% to US$63.94 each as analysts expect the sports shoe and  clothing giant to post quarterly earnings at $0.4 per share on revenue of $8.39 billion after the closing bell.

Quick facts: ConAgra Brands Inc

Price: 29.8 USD

NYSE:CAG
Market: NYSE
Market Cap: $14.51 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Empower Clinics reformulates Sollievo product line to...

Empower Clinics (CSE: CBDT-OTC: EPWCF) Chairman and CEO Steven McAuley joined Steve Darling in the Vancouver studio of Proactive to bring news the company has launched a series of re-formulated versions of its CBD tincture product line Sollievo. McAuley talks about why they did it and how...

9 hours, 29 minutes ago

2 min read